Clinical profile, visual outcome and quality of life in patients undergoing pan retinal photocoagulation for proliferative diabetic retinopathy

Not yet recruiting

Brief Summary: Diabetesmellitus (D.M.) is a major medical problem throughout the world. The prevalence of diabetes in India is 2.4% in the rural population and 4.0-11.6% in the urban population. It is estimated that 20% of the currentglobal diabetic population resides in the Southeast Asia region.Worldwide 150 millioncases are currentlydiagnosed, predicted to bedoubled by 2025. India is committed to an initiative of Vision 2020: The Right to Sight, thus having targetsfor ophthalmic infrastructure in its tenth five-year plan. Diabetes mellitus (D.M.) is a significant cause of avoidable blindness in both developing and developed countries.Patients with diabetic retinopathy (DR) are 25 times more likely to becomeblind than non-diabetics. In thenatural course, approximately 50% of patients with very severe N.P.D.R. (non-proliferative diabeticretinopathy) progress to PDR (proliferative diabetic retinopathy) within1 year. Panretinal photocoagulation (P.R.P.) is the preferred form oftreatment for proliferative diabetic retinopathy (P.D.R.). The DRSfound that PRP (pan retinal photocoagulation) prevented severe visual loss by over 50% at 2 and 4 years of followup. However,many studies have been done on pan-retinal photocoagulation for proliferative diabetic retinopathy. The aim of this study is to observe the clinicalprofile, visual outcome and quality of life in patients undergoing pan-retinal photocoagulation for proliferative diabetic retinopathy.

Recruitment & Eligibility

Inclusion Criteria

Patients with diabetes type 1 or diabetes type 2 having Proliferative diabetic retinopathy.
Patients of age 40 years or above Patients willing to undergo and fit for pan retinal Photocoagulation Procedure.
Patients consenting for follow up visits at 1 month, 6 month and 1 year.

Exclusion Criteria

Patients with non-proliferative diabetic retinopathy (NPDR)/ severe NPDR.
Patients receiving additional ocular intervention such as intravitreal injection or cataract surgery.
Patients with gestational diabetes.
Patients with corneal opacities deleteriously affecting their visual acuity.
Patient below age of 40 years.

Primary Outcome Measures

Name	Time	Method
Prevalence of proliferative diabetic retinopathy is more in diabetics of 40 years age or above as compared to diabetics with age below 40 years	1 month 6 months and 1 year
Improvement in quality of life & visual outcome of patients undergoing pan retinal photocoagulation for proliferative diabetic retinopathy is much greater compared other treatment methods	1 month 6 months and 1 year

Secondary Outcome Measures

Name	Time	Method

Locations (1): Jawaharlal Nehru Medical College
🇮🇳
Wardha, MAHARASHTRA, India
Jawaharlal Nehru Medical College
🇮🇳Wardha, MAHARASHTRA, India
DR MEGHAVI PANDYA
Principal investigator
09408771706
meghavi17@gmail.com